NSE: KPL · Healthcare · Pharmaceuticals · Market cap ₹3,963 Cr
· Prev close ₹3,686.00 · Volume 56.72 K · 52W ₹1,561–3,949
Day range for 9 Nov not in the price history yet · 8 Nov ₹3,642.70–3,749.90
Last 4 quarters: profit +86.7% on the 4 beforeShare price +4.3% in a month
If profit compounds at 0.0% (CAGR) and the stock ends at 25×, buying at ₹3,819 returns about −6.5% CAGR over 10 years.
| Growth assumption | Profit growth (CAGR) | Return, 10Y CAGR |
|---|---|---|
| Yours | 0.0% | −6.5% |
| Delivered FY22–26 | −13.4% | −19.1% |
| Net profit, last 4 quarters vs the 4 before | 86.7% | 74.6% |
| Half the delivered pace | −6.7% | −12.8% |
Delivered FY22–26 CAGR −13.4%
This is an exit-multiple calculation, not a discounted cash flow. Inputs: EPS for the 4 quarters Sep 2025 to Jun 2026 ₹78.10, price ₹3,819.40 (9 Nov 2026, 2:47 pm IST price). Formula: return = (EPS × exit P/E ÷ price)^(1/10) × (1 + growth) − 1. Net profit growth is applied to EPS, so the share count is held constant. A profit fall of 100% or more has no rate and is left blank. Dividends ignored. Arithmetic, not a forecast.